Showing results 13 to 13 of 13
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival Journal:Asia-Pacific Journal of Clinical Oncology | 2021 |